跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,414 条关于
“Pluton Asset Holding AG”
全部
6,414
临床试验
2,863
药物
453
机构
582
资讯
2,516
10个月前
Captain T Cell Secures €20 Million to Advance Next-Generation TCR-T Therapies for Solid Tumors
去年
NCI and NIDDK Initiate Phase II Trial of PentixaFor for Adrenal Tumor Subtyping
10个月前
Curatis Secures CHF 1.2 Million to Accelerate Late-Stage Corticorelin Development
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
去年
Sareum Holdings Raises £2.4 Million to Advance TYK2/JAK1 Inhibitor SDC-1801
3年前
4SC's Resminostat Advances Towards European Market Approval for CTCL Maintenance Therapy
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
5个月前
HMH Holding Completes $210.4 Million IPO Pricing for Drilling Equipment Technology
去年
BRAIN Biotech AG Secures €128.88 Million Royalty Monetization Deal for Deucrictibant
第 1 页,共 252 页
上一页
下一页